Boston Partners Trimmed Holding in Curtiss Wright (CW) by $2.17 Million; United Capital Financial Advisers Raised Its Abbott Labs (ABT) Holding by $378,138; Stock Price Rose

Curtiss-Wright Corporation (NYSE:CW) Logo

Boston Partners decreased its stake in Curtiss Wright Corp (CW) by 1.32% based on its latest 2017Q4 regulatory filing with the SEC. Boston Partners sold 17,956 shares as the company’s stock rose 9.37% while stock markets declined. The institutional investor held 1.34M shares of the industrial machinery and components company at the end of 2017Q4, valued at $163.72M, down from 1.36 million at the end of the previous reported quarter. Boston Partners who had been investing in Curtiss Wright Corp for a number of months, seems to be less bullish one the $5.82B market cap company. The stock decreased 0.27% or $0.36 during the last trading session, reaching $131.49. About 262,196 shares traded or 14.95% up from the average. Curtiss-Wright Corporation (NYSE:CW) has risen 47.95% since April 29, 2017 and is uptrending. It has outperformed by 36.40% the S&P500.

United Capital Financial Advisers Llc increased its stake in Abbott Labs (ABT) by 1.29% based on its latest 2017Q4 regulatory filing with the SEC. United Capital Financial Advisers Llc bought 6,634 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 520,718 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $29.92 million, up from 514,084 at the end of the previous reported quarter. United Capital Financial Advisers Llc who had been investing in Abbott Labs for a number of months, seems to be bullish on the $104.01B market cap company. The stock increased 0.10% or $0.06 during the last trading session, reaching $59.56. About 4.14M shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 29, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Since December 14, 2017, it had 1 buying transaction, and 19 insider sales for $23.57 million activity. Watkin Jared sold 996 shares worth $58,635. 1,053 shares were sold by Bracken Sharon J, worth $62,056. $2.69M worth of stock was sold by Ford Robert B on Tuesday, January 30. Fussell Stephen R sold 11,106 shares worth $667,804. 40,037 shares were bought by STARKS DANIEL J, worth $2.43M. The insider Salvadori Daniel Gesua Sive sold 28,319 shares worth $1.56M.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by Jefferies on Monday, December 7. The firm has “Market Perform” rating given on Tuesday, March 14 by BMO Capital Markets. The firm has “Outperform” rating given on Monday, August 10 by Credit Suisse. The rating was maintained by Stifel Nicolaus on Thursday, July 23 with “Buy”. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, July 23. The stock has “Buy” rating by RBC Capital Markets on Wednesday, January 24. The stock of Abbott Laboratories (NYSE:ABT) has “Outperform” rating given on Wednesday, March 1 by RBC Capital Markets. Morgan Stanley maintained Abbott Laboratories (NYSE:ABT) on Thursday, October 19 with “Equal-Weight” rating. The firm has “Buy” rating by BTIG Research given on Saturday, August 29. As per Thursday, January 25, the company rating was maintained by Guggenheim.

United Capital Financial Advisers Llc, which manages about $9.56B and $12.67 billion US Long portfolio, decreased its stake in Masco Corp (NYSE:MAS) by 40,703 shares to 38,657 shares, valued at $1.70 million in 2017Q4, according to the filing. It also reduced its holding in Microsoft Corp. (NASDAQ:MSFT) by 27,350 shares in the quarter, leaving it with 1.07M shares, and cut its stake in Anadarko Petroleum (NYSE:APC).

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It is positive, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Picton Mahoney Asset Mngmt has 433,800 shares for 0.66% of their portfolio. Trexquant Invest Lp has 11,254 shares for 0.07% of their portfolio. 45,384 were reported by Freestone Cap Ltd Llc. Oppenheimer Asset Management has 369,008 shares for 0.52% of their portfolio. Wealthtrust stated it has 1,582 shares. Monetary Mngmt holds 0.55% or 23,795 shares. Wade G W holds 0.08% or 11,745 shares. Raymond James Assoc invested in 1.94M shares. Old West Mgmt Lc owns 151,413 shares. West Family Invests invested in 22,000 shares or 0.32% of the stock. Private Wealth Inc reported 10,042 shares. Parallax Volatility Advisers Lp stated it has 0.01% in Abbott Laboratories (NYSE:ABT). Transamerica Advisors has invested 0% in Abbott Laboratories (NYSE:ABT). Fayez Sarofim & holds 4.06M shares. Holderness Co invested in 0.31% or 11,023 shares.

Boston Partners, which manages about $53.18B and $84.89B US Long portfolio, upped its stake in Amc Networks Inc (NASDAQ:AMCX) by 430,169 shares to 819,011 shares, valued at $44.29 million in 2017Q4, according to the filing. It also increased its holding in Great Plains Energy Inc (NYSE:GXP) by 90,219 shares in the quarter, for a total of 2.44 million shares, and has risen its stake in Rpx Corp (NASDAQ:RPXC).

Since October 30, 2017, it had 5 insider buys, and 2 sales for $2.45 million activity. 1,300 shares were sold by Nathman John B, worth $152,462. Shares for $21,189 were bought by Quinly Tom P on Tuesday, January 9. On Tuesday, January 9 Jakubowitz Harry bought $6,993 worth of Curtiss-Wright Corporation (NYSE:CW) or 67 shares. Ferdenzi Paul J also bought $8,350 worth of Curtiss-Wright Corporation (NYSE:CW) shares. The insider FULLER S MARCE sold $169,862. 17,414 shares were sold by Adams David Charles, worth $2.35 million on Wednesday, March 7.

Analysts await Curtiss-Wright Corporation (NYSE:CW) to report earnings on May, 2 after the close. They expect $0.92 EPS, up 43.75% or $0.28 from last year’s $0.64 per share. CW’s profit will be $40.71M for 35.73 P/E if the $0.92 EPS becomes a reality. After $1.75 actual EPS reported by Curtiss-Wright Corporation for the previous quarter, Wall Street now forecasts -47.43% negative EPS growth.

Among 9 analysts covering Curtiss-Wright (NYSE:CW), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Curtiss-Wright had 26 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Buy” rating by Deutsche Bank given on Friday, October 6. The stock has “Hold” rating by Stifel Nicolaus on Friday, October 27. CL King initiated the shares of CW in report on Friday, October 16 with “Buy” rating. SunTrust initiated the shares of CW in report on Thursday, January 19 with “Hold” rating. SunTrust maintained Curtiss-Wright Corporation (NYSE:CW) on Thursday, October 26 with “Buy” rating. Bank of America downgraded the shares of CW in report on Friday, November 11 to “Neutral” rating. The rating was maintained by SunTrust with “Buy” on Thursday, February 22. Stifel Nicolaus maintained Curtiss-Wright Corporation (NYSE:CW) on Friday, February 23 with “Hold” rating. Stifel Nicolaus initiated it with “Hold” rating and $100.0 target in Monday, September 18 report. On Sunday, October 15 the stock rating was maintained by Stifel Nicolaus with “Hold”.

Investors sentiment increased to 1.31 in 2017 Q4. Its up 0.07, from 1.24 in 2017Q3. It increased, as 5 investors sold CW shares while 84 reduced holdings. 48 funds opened positions while 69 raised stakes. 33.56 million shares or 2.16% more from 32.85 million shares in 2017Q3 were reported. Whittier Tru holds 0.07% of its portfolio in Curtiss-Wright Corporation (NYSE:CW) for 16,246 shares. Jpmorgan Chase And Com reported 0.01% of its portfolio in Curtiss-Wright Corporation (NYSE:CW). Tiaa Cref Inv Mngmt Limited Company accumulated 217,895 shares or 0.02% of the stock. Jefferies Limited Liability Com stated it has 0% in Curtiss-Wright Corporation (NYSE:CW). Acadian Asset Mngmt Limited Liability Company reported 22,756 shares or 0.01% of all its holdings. Invesco Ltd reported 0.01% stake. Schroder Inv Mngmt Group reported 0.01% stake. Morgan Stanley has 315,214 shares for 0.01% of their portfolio. Metropolitan Life Com New York owns 25,203 shares. First Limited Partnership invested in 0% or 11,241 shares. Moreover, Qs Limited Liability has 0.05% invested in Curtiss-Wright Corporation (NYSE:CW). Duncker Streett & Co stated it has 800 shares. Bessemer Grp reported 0.01% of its portfolio in Curtiss-Wright Corporation (NYSE:CW). Citigroup, New York-based fund reported 30,534 shares. Massachusetts-based Welch & Forbes Llc has invested 0.01% in Curtiss-Wright Corporation (NYSE:CW).

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart